Loading...
EPI-001, a compound active against castration-resistant prostate cancer, targets transactivation unit 5 of the androgen receptor
Castration-resistant prostate cancer is the lethal condition suffered by prostate cancer patients that become refractory to androgen deprivation therapy. EPI-001 is a recently identified compound active against this condition that modulates the activity of the androgen receptor, a nuclear receptor t...
Na minha lista:
| Udgivet i: | ACS Chem Biol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5027137/ https://ncbi.nlm.nih.gov/pubmed/27356095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.6b00182 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|